US Stock MarketDetailed Quotes

VERV Verve Therapeutics

Watchlist
  • 5.380
  • -0.130-2.36%
Close Sep 19 16:00 ET
  • 5.470
  • +0.090+1.67%
Post 20:01 ET
455.28MMarket Cap-2077P/E (TTM)

Verve Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
219.73%6.69M
305.63%5.7M
505.77%11.76M
408.30%5.14M
235.52%3.12M
2.09M
1.4M
1.94M
1.01M
929K
Operating revenue
219.73%6.69M
305.63%5.7M
505.77%11.76M
408.30%5.14M
235.52%3.12M
--2.09M
--1.4M
--1.94M
--1.01M
--929K
Cost of revenue
Gross profit
Operating expense
8.00%65.53M
4.82%62.54M
40.12%234.88M
21.28%59.09M
23.80%55.45M
43.81%60.68M
86.88%59.66M
92.53%167.63M
49.73%48.72M
90.58%44.79M
Selling and administrative expenses
8.43%14.55M
12.83%14.16M
33.05%49.94M
7.37%12.28M
21.83%11.69M
47.97%13.42M
68.84%12.55M
98.96%37.53M
73.28%11.44M
59.68%9.59M
-General and administrative expense
8.43%14.55M
12.83%14.16M
33.05%49.94M
7.37%12.28M
21.83%11.69M
47.97%13.42M
68.84%12.55M
98.96%37.53M
73.28%11.44M
59.68%9.59M
Research and development costs
7.88%50.98M
2.69%48.38M
42.16%184.95M
25.55%46.81M
24.34%43.77M
42.67%47.26M
92.36%47.11M
90.75%130.1M
43.74%37.28M
101.18%35.2M
Operating profit
-0.44%-58.84M
2.43%-56.84M
-34.67%-223.12M
-13.07%-53.95M
-19.32%-52.33M
-38.85%-58.58M
-82.49%-58.26M
-90.30%-165.69M
-46.62%-47.71M
-86.62%-43.86M
Net non-operating interest income expense
36.61%7.43M
46.70%8.14M
237.35%23.17M
40.88%6.34M
195.60%5.84M
1,665.58%5.44M
6,663.41%5.55M
4,735.92%6.87M
6,932.81%4.5M
3,628.30%1.98M
Non-operating interest income
36.61%7.43M
46.70%8.14M
----
----
195.60%5.84M
1,665.58%5.44M
6,663.41%5.55M
----
----
3,628.30%1.98M
Total other finance cost
----
----
-237.35%-23.17M
----
----
----
----
-4,735.92%-6.87M
----
----
Other net income (expense)
352.42%1.67M
-89.43%78K
-88.90%165K
-132.75%-713K
124.26%802K
-170.58%-662K
-55.99%738K
104.45%1.49M
91.13%2.18M
-572.29%-3.31M
Other non- operating income (expenses)
352.42%1.67M
-89.43%78K
-88.90%165K
-132.75%-713K
124.26%802K
-170.58%-662K
-55.99%738K
104.45%1.49M
91.13%2.18M
-572.29%-3.31M
Income before tax
7.56%-49.74M
6.44%-48.63M
-26.99%-199.79M
-17.76%-48.32M
-1.11%-45.69M
-31.41%-53.81M
-72.30%-51.98M
-30.77%-157.33M
-30.94%-41.03M
-98.65%-45.19M
Income tax
-62.50%66K
106K
418.87%275K
-39.62%32K
67K
176K
0
53K
53K
0
Net income
7.74%-49.81M
6.23%-48.74M
-27.12%-200.07M
-17.69%-48.35M
-1.26%-45.76M
-31.84%-53.98M
-72.30%-51.98M
-30.81%-157.39M
-31.11%-41.09M
-98.65%-45.19M
Net income continuous Operations
7.74%-49.81M
6.23%-48.74M
-27.12%-200.07M
-17.69%-48.35M
-1.26%-45.76M
-31.84%-53.98M
-72.30%-51.98M
-30.81%-157.39M
-31.11%-41.09M
-98.65%-45.19M
Minority interest income
Net income attributable to the parent company
7.74%-49.81M
6.23%-48.74M
-27.12%-200.07M
-17.69%-48.35M
-1.26%-45.76M
-31.84%-53.98M
-72.30%-51.98M
-30.81%-157.39M
-31.11%-41.09M
-98.65%-45.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
7.74%-49.81M
6.23%-48.74M
-27.12%-200.07M
-17.69%-48.35M
-1.26%-45.76M
-31.84%-53.98M
-72.30%-51.98M
-30.81%-157.39M
-31.11%-41.09M
-98.65%-45.19M
Basic earnings per share
32.18%-0.59
29.76%-0.59
-7.22%-3.12
-2.99%-0.69
8.86%-0.72
-3.57%-0.87
-35.48%-0.84
35.04%-2.91
-3.08%-0.67
-68.09%-0.79
Diluted earnings per share
32.18%-0.59
29.76%-0.59
-7.22%-3.12
-2.99%-0.69
8.86%-0.72
-3.57%-0.87
-35.48%-0.84
35.04%-2.91
-3.08%-0.67
-68.09%-0.79
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 219.73%6.69M305.63%5.7M505.77%11.76M408.30%5.14M235.52%3.12M2.09M1.4M1.94M1.01M929K
Operating revenue 219.73%6.69M305.63%5.7M505.77%11.76M408.30%5.14M235.52%3.12M--2.09M--1.4M--1.94M--1.01M--929K
Cost of revenue
Gross profit
Operating expense 8.00%65.53M4.82%62.54M40.12%234.88M21.28%59.09M23.80%55.45M43.81%60.68M86.88%59.66M92.53%167.63M49.73%48.72M90.58%44.79M
Selling and administrative expenses 8.43%14.55M12.83%14.16M33.05%49.94M7.37%12.28M21.83%11.69M47.97%13.42M68.84%12.55M98.96%37.53M73.28%11.44M59.68%9.59M
-General and administrative expense 8.43%14.55M12.83%14.16M33.05%49.94M7.37%12.28M21.83%11.69M47.97%13.42M68.84%12.55M98.96%37.53M73.28%11.44M59.68%9.59M
Research and development costs 7.88%50.98M2.69%48.38M42.16%184.95M25.55%46.81M24.34%43.77M42.67%47.26M92.36%47.11M90.75%130.1M43.74%37.28M101.18%35.2M
Operating profit -0.44%-58.84M2.43%-56.84M-34.67%-223.12M-13.07%-53.95M-19.32%-52.33M-38.85%-58.58M-82.49%-58.26M-90.30%-165.69M-46.62%-47.71M-86.62%-43.86M
Net non-operating interest income expense 36.61%7.43M46.70%8.14M237.35%23.17M40.88%6.34M195.60%5.84M1,665.58%5.44M6,663.41%5.55M4,735.92%6.87M6,932.81%4.5M3,628.30%1.98M
Non-operating interest income 36.61%7.43M46.70%8.14M--------195.60%5.84M1,665.58%5.44M6,663.41%5.55M--------3,628.30%1.98M
Total other finance cost ---------237.35%-23.17M-----------------4,735.92%-6.87M--------
Other net income (expense) 352.42%1.67M-89.43%78K-88.90%165K-132.75%-713K124.26%802K-170.58%-662K-55.99%738K104.45%1.49M91.13%2.18M-572.29%-3.31M
Other non- operating income (expenses) 352.42%1.67M-89.43%78K-88.90%165K-132.75%-713K124.26%802K-170.58%-662K-55.99%738K104.45%1.49M91.13%2.18M-572.29%-3.31M
Income before tax 7.56%-49.74M6.44%-48.63M-26.99%-199.79M-17.76%-48.32M-1.11%-45.69M-31.41%-53.81M-72.30%-51.98M-30.77%-157.33M-30.94%-41.03M-98.65%-45.19M
Income tax -62.50%66K106K418.87%275K-39.62%32K67K176K053K53K0
Net income 7.74%-49.81M6.23%-48.74M-27.12%-200.07M-17.69%-48.35M-1.26%-45.76M-31.84%-53.98M-72.30%-51.98M-30.81%-157.39M-31.11%-41.09M-98.65%-45.19M
Net income continuous Operations 7.74%-49.81M6.23%-48.74M-27.12%-200.07M-17.69%-48.35M-1.26%-45.76M-31.84%-53.98M-72.30%-51.98M-30.81%-157.39M-31.11%-41.09M-98.65%-45.19M
Minority interest income
Net income attributable to the parent company 7.74%-49.81M6.23%-48.74M-27.12%-200.07M-17.69%-48.35M-1.26%-45.76M-31.84%-53.98M-72.30%-51.98M-30.81%-157.39M-31.11%-41.09M-98.65%-45.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 7.74%-49.81M6.23%-48.74M-27.12%-200.07M-17.69%-48.35M-1.26%-45.76M-31.84%-53.98M-72.30%-51.98M-30.81%-157.39M-31.11%-41.09M-98.65%-45.19M
Basic earnings per share 32.18%-0.5929.76%-0.59-7.22%-3.12-2.99%-0.698.86%-0.72-3.57%-0.87-35.48%-0.8435.04%-2.91-3.08%-0.67-68.09%-0.79
Diluted earnings per share 32.18%-0.5929.76%-0.59-7.22%-3.12-2.99%-0.698.86%-0.72-3.57%-0.87-35.48%-0.8435.04%-2.91-3.08%-0.67-68.09%-0.79
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data